NZ630125A - Herbal composition for the treatment of metabolic disorders - Google Patents

Herbal composition for the treatment of metabolic disorders

Info

Publication number
NZ630125A
NZ630125A NZ630125A NZ63012513A NZ630125A NZ 630125 A NZ630125 A NZ 630125A NZ 630125 A NZ630125 A NZ 630125A NZ 63012513 A NZ63012513 A NZ 63012513A NZ 630125 A NZ630125 A NZ 630125A
Authority
NZ
New Zealand
Prior art keywords
herbal composition
treatment
metabolic disorders
disclosed
composition
Prior art date
Application number
NZ630125A
Other languages
English (en)
Inventor
Arvind Saklani
Parikshit Gaikwad
Aslam Burhan
Somesh Sharma
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of NZ630125A publication Critical patent/NZ630125A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
NZ630125A 2012-03-13 2013-03-12 Herbal composition for the treatment of metabolic disorders NZ630125A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261610002P 2012-03-13 2012-03-13
PCT/IB2013/051925 WO2013136257A1 (en) 2012-03-13 2013-03-12 Herbal composition for the treatment of metabolic disorders

Publications (1)

Publication Number Publication Date
NZ630125A true NZ630125A (en) 2017-01-27

Family

ID=49160323

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ630125A NZ630125A (en) 2012-03-13 2013-03-12 Herbal composition for the treatment of metabolic disorders

Country Status (13)

Country Link
US (1) US20150050373A1 (enExample)
EP (1) EP2825183A4 (enExample)
JP (1) JP2015509976A (enExample)
KR (1) KR20140138275A (enExample)
CN (1) CN104203258A (enExample)
AU (1) AU2013233930A1 (enExample)
CA (1) CA2866260A1 (enExample)
IL (1) IL234616A0 (enExample)
IN (1) IN2014MN01933A (enExample)
MX (1) MX2014010926A (enExample)
NZ (1) NZ630125A (enExample)
RU (1) RU2014140852A (enExample)
WO (1) WO2013136257A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069475B (zh) 2016-04-22 2022-01-28 受体控股公司 快速作用植物类医药化合物和营养补剂
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
US12303487B2 (en) 2018-11-19 2025-05-20 Spoke Sciences, Inc. N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions
US20220214367A1 (en) * 2019-04-15 2022-07-07 Board Of Regents, The University Of Texas System Calibration methods and compositions for biomolecule analysis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
US6774141B1 (en) * 1992-03-31 2004-08-10 The United States Of America As Represented By The Secretary Of Health And Human Services Calanolide and related antiviral compounds, compositions, and uses thereof
JP4195728B2 (ja) * 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ，インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
FR2794973B1 (fr) * 1999-06-18 2001-09-14 Mousny Brigitte Utilisation d'huile de plantes du genre calophyllum extraite a temperature ambiante dans des compositions cosmetiques, dietetiques et therapeutiques
JP2001192317A (ja) * 2000-01-06 2001-07-17 Shiseido Co Ltd マトリックスメタロプロテアーゼ阻害剤
JP2005272326A (ja) * 2004-03-23 2005-10-06 A Pharma Kindai Co Ltd 抗アレルギー剤、抗掻痒剤、及び抗菌剤
FR2886547B1 (fr) * 2005-06-02 2009-06-05 Boucher Claude Henri Marie Ghi Composition cosmetique, dietetique, pharmaceutique obtenue a partir d'huile non raffinee exempte d'acides gras trans, d'esters phorboliques, extraite sans solvant
PT2529626T (pt) * 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
JP2008081440A (ja) * 2006-09-27 2008-04-10 Noevir Co Ltd アロマターゼ活性促進剤
AU2007336238A1 (en) * 2006-12-20 2008-06-26 Novartis Ag 2-substituted 5-membered heterocycles as SCD inhibitors
FR2915095B1 (fr) * 2007-04-17 2013-08-23 Diaye Yacine Isabelle Monique N Creme de soin
US20100135945A1 (en) * 2008-12-02 2010-06-03 Kreations By Kristin, Llc Gymnema-containing lip balm compositions and associated methods
US8821948B2 (en) * 2010-03-04 2014-09-02 Steva A. Komeh-Nkrumah Therapeutic, bio-affecting and body treating composition

Also Published As

Publication number Publication date
RU2014140852A (ru) 2016-05-10
CN104203258A (zh) 2014-12-10
IN2014MN01933A (enExample) 2015-07-10
JP2015509976A (ja) 2015-04-02
AU2013233930A1 (en) 2014-09-25
KR20140138275A (ko) 2014-12-03
EP2825183A1 (en) 2015-01-21
US20150050373A1 (en) 2015-02-19
CA2866260A1 (en) 2013-09-19
EP2825183A4 (en) 2015-09-23
MX2014010926A (es) 2015-04-10
IL234616A0 (en) 2014-11-30
WO2013136257A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
MY201670A (en) Condensed imidazolylimidazoles as antiviral compounds
IN2014MN02269A (enExample)
EA201491028A1 (ru) Способ получения замещенных 5-фтор-1н-пиразолопиридинов
MX344521B (es) Aminas heterociclicas y sus usos.
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
HK1215579A1 (zh) 被取代的2，3-二氫苯並呋喃基化合物和其用途
MY184858A (en) Substituted pyridopyrimidine compounds and their use as flt3 inhibitors
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
MY191352A (en) Aldosterone synthase inhibitors
PH12016500775A1 (en) Herbal composition, process for its preparation and use thereof
MX2013006670A (es) Derivado de 2-carboxamida-4-piperazinil-benzofurano.
IN2014MN01933A (enExample)
HK1211239A1 (en) Treatment regimens
GB2498677A (en) Extracts of cynanchum SP.and active ingredients contained therein in use of arthritis treatment
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
WO2014106826A3 (en) Anthracycline analogue and uses thereof
MX368641B (es) Compuestos para el tratamiento de inflamación y dolor.
NZ629475A (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
MX366970B (es) Nuevo uso farmacologico de extracto de cimicifuga.
WO2012093919A3 (ko) 백혈병 치료용 조성물 및 몰약 추출물의 제조방법
WO2012096463A3 (ko) 복합 생약 추출물을 유효성분으로 함유하는 알러지성 또는 비알러지성 피부 질환의 예방 및 개선용 조성물 및 이의 용도
WO2012138190A3 (ko) 병아리꽃나무 추출물을 포함하는 조성물
WO2012134168A3 (ko) 영릉향 추출물을 포함하는 폐암 치료용 조성물 및 화장료 조성물
IN2012CH04487A (enExample)
UA74882U (uk) Фармацевтична композиція для лікування сексуальної дисфункції

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed